Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (2) Autor Barber,Katie E. (1) Bell,Allison M. (1) Gomes-da-Silva,Monica Maria (1) King,S. Travis (1) Okumura,Lucas Miyake (1) Parham,Jason J. (1) Riveros,Bruno Salgado (1) Stover,Kayla R. (1) Veroneze,Izelandia (1) Mais... Palavra-chave Antimicrobial stewardship program (2) Cost-effectiveness (1) Meropenem (1) Mortality (1) Pharmaceutical (1) Pharmacist (1) Piperacillin (1) Mais... Tipo do documento Info:eu-repo/semantics/article (1) Info:eu-repo/semantics/other (1) Ano 2016 (2) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última A cost-effectiveness analysis of two different antimicrobial stewardship programs BJID Okumura,Lucas Miyake; Riveros,Bruno Salgado; Gomes-da-Silva,Monica Maria; Veroneze,Izelandia. Abstract There is a lack of formal economic analysis to assess the efficiency of antimicrobial stewardship programs. Herein, we conducted a cost-effectiveness study to assess two different strategies of Antimicrobial Stewardship Programs. A 30-day Markov model was developed to analyze how cost-effective was a Bundled Antimicrobial Stewardship implemented in a university hospital in Brazil. Clinical data derived from a historical cohort that compared two different strategies of antimicrobial stewardship programs and had 30-day mortality as main outcome. Selected costs included: workload, cost of defined daily doses, length of stay, laboratory and imaging resources used to diagnose infections. Data were analyzed by deterministic and probabilistic sensitivity... Tipo: Info:eu-repo/semantics/article Palavras-chave: Antimicrobial stewardship program; Cost-effectiveness; Mortality; Pharmacist. Ano: 2016 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000300006 Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs BJID Barber,Katie E.; Bell,Allison M.; King,S. Travis; Parham,Jason J.; Stover,Kayla R.. ABSTRACT Drug shortages pose a clear detriment to antimicrobial stewardship (AS) efforts. Our objective was to evaluate the effect of a piperacillin-tazobactam shortage on meropenem use, related costs, and associated changes in AS activity. A quasi-experimental quality improvement review compared adult patients receiving meropenem ≥72 h three months pre-shortage and three months during the shortage. 320 patients were included (pre-shortage: 103; shortage: 217). Baseline characteristics were similar, but the length of stay was slightly longer in pre-shortage [19 (11-32) days] versus shortage [16 (11-32) days] (p = 0.094). In pre-shortage and shortage, median days of therapy and estimated meropenem cost were 7 (5-11) and 7 (5-10) and $309.93... Tipo: Info:eu-repo/semantics/other Palavras-chave: Piperacillin; Meropenem; Pharmaceutical; Antimicrobial stewardship program. Ano: 2016 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702016000600631 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco